פרווימיס 480 מג טבליות מצופות ישראל - עברית - Ministry of Health

פרווימיס 480 מג טבליות מצופות

merck sharp & dohme (israel - 1996) company ltd, israel - letermovir - טבליות מצופות פילם - letermovir 480 mg - letermovir

גרדסיל ישראל - עברית - Ministry of Health

גרדסיל

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

קו-דיובאן 8012.5 מג טבליות מצופות ישראל - עברית - Ministry of Health

קו-דיובאן 8012.5 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

קו-דיובאן 16012.5 מג טבליות מצופות ישראל - עברית - Ministry of Health

קו-דיובאן 16012.5 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

קו-דיובאן 16025 מג טבליות מצופות ישראל - עברית - Ministry of Health

קו-דיובאן 16025 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

ולטרקס טבליות 500 מג ישראל - עברית - Ministry of Health

ולטרקס טבליות 500 מג

glaxo smith kline (israel) ltd - valaciclovir as hydrochloride - טבליות מצופות פילם - valaciclovir as hydrochloride 500 mg - valaciclovir - valaciclovir - valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established. valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).

ואלאציקלוביר טבע ® 500 מ"ג ישראל - עברית - Ministry of Health

ואלאציקלוביר טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - valaciclovir hydrochloride (as dihydrate) 500 mg - film coated tablets - valaciclovir - valaciclovir teva is indicated for the treatment of herpes zoster (shingles) in immunocompetent adults . valaciclovir teva accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir teva in immunocompromised patients has not been established. - valaciclovir teva is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. - valaciclovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). - prophylaxis of cytomegalovirus infection and disease, following organ transplantation. - for the treatment of cold sores (herpes labialis).

ולוויר ישראל - עברית - Ministry of Health

ולוויר

rafa laboratories ltd - valaciclovir as hydrochloride 500 mg - film coated tablets - valaciclovir - valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established.valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).

ואלציט ישראל - עברית - Ministry of Health

ואלציט

roche pharmaceuticals (israel) ltd - valganciclovir 450 mg - film coated tablets - valganciclovir - valcyte is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prevention of cmv diseasein cmv-negative patients who have received a solid organ transplant from a cmv-positive donor.

ג'קאבי 5 מג ישראל - עברית - Ministry of Health

ג'קאבי 5 מג

novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 5 mg - ruxolitinib - ruxolitinib - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.